Midcap Value Alert: 3 Years of Subscription at the Price of 1
Here is the latest financial fact sheet of DR HABEEBULLAH LIFE SCIENCES. For more details, see the DR HABEEBULLAH LIFE SCIENCES quarterly results and DR HABEEBULLAH LIFE SCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 5.2 |
No. of shares | m | 14.81 |
1 Week | % | 1.1 |
1 Month | % | 9.2 |
1 Year | % | -17.7 |
52 week H/L | Rs | 22.0/13.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
DR HABEEBULLAH LIFE SCIENCES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 59 | 76 | 66 | 48 | 38 | |
Low | Rs | 28 | 26 | 30 | 23 | 18 | |
Sales per share (Unadj.) | Rs | 1.5 | 1.0 | 0 | 0 | 0 | |
Earnings per share (Unadj.) | Rs | -1.7 | -1.3 | -0.5 | 1.0 | -0.5 | |
Diluted earnings per share | Rs | -1.6 | -1.3 | -0.5 | 1.0 | -0.5 | |
Cash flow per share (Unadj.) | Rs | -1.7 | -1.3 | -0.5 | 1.0 | -0.5 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 8.5 | 8.0 | 7.5 | 8.9 | 8.5 | |
Adj. book value per share | Rs | 7.9 | 8.0 | 7.5 | 8.9 | 8.5 | |
Shares outstanding (eoy) | m | 13.81 | 14.81 | 14.81 | 14.81 | 14.81 | |
Price / Sales ratio | x | 29.8 | 52.7 | 5,419.4 | 2,331.5 | 1,907.1 | |
Avg P/E ratio | x | -25.8 | -38.1 | -91.5 | 35.0 | -58.8 | |
P/CF ratio (eoy) | x | -26.0 | -38.4 | -92.7 | 34.9 | -59.1 | |
Price / Book Value ratio | x | 5.1 | 6.4 | 6.3 | 4.0 | 3.3 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 601 | 754 | 705 | 525 | 415 | |
Total wages/salary | Rs m | 15 | 14 | 3 | 1 | 1 |
DR HABEEBULLAH LIFE SCIENCES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 20 | 14 | 0 | 0 | 0 | |
Other income | Rs m | 1 | 2 | 1 | 19 | 3 | |
Total revenues | Rs m | 21 | 16 | 2 | 19 | 3 | |
Gross profit | Rs m | -24 | -22 | -9 | -4 | -10 | |
Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit before tax | Rs m | -24 | -21 | -8 | 15 | -7 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | -1 | 0 | 0 | 0 | |
Profit after tax | Rs m | -23 | -20 | -8 | 15 | -7 | |
Gross profit margin | % | -121.2 | -152.7 | -6,963.1 | -1,812.2 | -4,481.3 | |
Effective tax rate | % | 1.1 | 3.5 | 0 | 0 | 0 | |
Net profit margin | % | -115.6 | -138.4 | -5,920.8 | 6,810.9 | -3,207.6 |
DR HABEEBULLAH LIFE SCIENCES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 58 | 66 | 70 | 71 | 55 | |
Current liabilities | Rs m | 98 | 123 | 54 | 38 | 30 | |
Net working cap to sales | % | -202.2 | -398.2 | 12,755.2 | 14,656.9 | 11,545.5 | |
Current ratio | x | 0.6 | 0.5 | 1.3 | 1.8 | 1.9 | |
Inventory Days | Days | 368 | 523 | 175,818 | 112,844 | 112,778 | |
Debtors Days | Days | 400,938,291 | 554,418,483 | 60,156,801,154 | 35,248,067 | 34,835,368 | |
Net fixed assets | Rs m | 201 | 212 | 95 | 101 | 101 | |
Share capital | Rs m | 138 | 148 | 148 | 148 | 148 | |
"Free" reserves | Rs m | -21 | -30 | -37 | -16 | -23 | |
Net worth | Rs m | 117 | 118 | 112 | 132 | 125 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 258 | 278 | 166 | 171 | 156 | |
Interest coverage | x | -391.5 | -255.6 | -255.7 | 375.5 | -704.0 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.1 | 0.1 | 0 | 0 | 0 | |
Return on assets | % | -9.0 | -7.1 | -4.6 | 8.8 | -4.5 | |
Return on equity | % | -19.9 | -16.8 | -6.9 | 11.3 | -5.6 | |
Return on capital | % | -20.1 | -17.4 | -6.9 | 11.4 | -5.6 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
DR HABEEBULLAH LIFE SCIENCES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -30 | -10 | -3 | -4 | 7 | |
From Investments | Rs m | -16 | -11 | -2 | 0 | 0 | |
From Financial Activity | Rs m | 42 | 22 | 5 | 4 | -7 | |
Net Cashflow | Rs m | -3 | 0 | -0 | 0 | -0 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: K Krishnam Raju | COMP SEC: Deepa Dudani | YEAR OF INC: 1996 | BSE CODE: 539267 | FV (Rs): 10 | DIV YIELD (%): - |
More Trading Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare DR HABEEBULLAH LIFE SCIENCES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian share markets made a cautious start on Monday in a week where inflation figures could make or break hopes for earlier US rate cuts.